Wikidata

(Q61933978)

English

Rosiglitazone-Metformin Combination Versus Metformin-Sulfonylurea Combination On Beta-Cell Function In Type 2 Diabetes

clinical trial

In more languages

Statements

title
Comparison of the Action of the Rosiglitazone-metformin Fixed-dose Combination and of a Metformin-sulfonylurea Free Combination on the B-cell Function in Type 2 Diabetic Patients Not Controlled With Metformin Alone. (English)
0 references
sponsor
GSK
0 references
start time
October 2004
0 references
end time
October 2008
0 references
number of participants
84
0 references
research intervention
(RS)-rosiglitazone
0 references
metformin
0 references
gliclazide
0 references
minimum age
40 year
0 references
maximum age
75 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61933978&oldid=2109357261"